A review of cycle control with a low-dose oral contraceptive containing 75 μg gestodene and 20 μg ethinylestradiol

Gynecological Endocrinology

Volumn 12, Issue SUPPL. 4, 1998, Pages 31-37

  Gast, M J ^a   Grubb, G ^a  

^a WYETH AYERST RESEARCH   (United States)

Author keywords

Cycle control; Ethinylestradiol; Gestodene; Low dose oral contraceptive

Indexed keywords

EID: 0003121778     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Fuchs N, Prinz H, Koch U. Attitudes to current oral contraceptive use and future developments: the woman's perspective. Eur J Contracept Reprod Health Care 1996;1:275-84
2. Rosenberg MJ, Long SC. Oral contraceptives and cycle control: a critical review of the literature. Adv Contracept 1992;8(Suppl l):35-45
3. Adams Hillard PJ. Oral contraception noncompliance: the extent of the problem. Adv Contracept 1992;8(Suppl 1):13-20
4. Rosenberg MJ, Waugh MS, Meehan TE. Use and misuse of oral contraceptives: risk indications for poor pill taking and discontinuation. Contraception 1995;51:283-8
5. Rosenberg MJ, Waugh, MS, Higgins JE. The effect of desogestrel, gestodene and other factors on spotting and bleeding. Contraception 1996;53:85-90
6. Barbosa IC, Aguiar LF, Aldrighi JM, et al. Clinical evaluation of a new gestodene monophasic oral contraceptive preparation containing 75 μg gestodene and 20 μg ethinyl estradiol. Contracept Fertil Sex 1995;23(Suppl.9):S41-42
7. Bitzer J, Bretscher J, Flamigni C, et al. Cycle control with a monophasic lower-estrogen-dose oral contraceptive containing 20 μg ethinylestradiol combined with 75 μg gestodene. Poster presentation at the 3rd European Society of Gynecological and Obstetric Investigation, Madonna di Campiglio, Italy, March 1997
8. Düsterberg B, Ellman H, Müller U, et al. A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodene. Gynecol Endocrinol 1996;10:33-9
9. Endrikat J, Jaques M-A, Mayerhofer M, et al. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol/150 μg desogestrel, with respect to efficacy, cycle control and tolerance. Contraception 1995;52:229-35
10. Fitzgerald C, Feichtinger W, Spona J, et al. A comparison of the effects of two monophasic low dose oral contraceptives on the inhibition of ovulation. Adv Contracept 1994;10:5-18
11. Wilde MI, Balfour JA. Gestodene. A review of its pharmacology, efficacy and tolerability in combined contraceptive preparations. Drugs 1995;50:364-95